Cotización GenSight Biologics - SIGHTP | ADVFN

US Dollar vs MXN

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

GenSight Biologics S.A. (SIGHTP)

0.294

0.00

( 0.00% )

Actualizado: 03:49:28

Realtime Data

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Último Precio

0.294

Postura de Compra

0.2785

Postura de Venta

0.2835

Volume Operado de la Acción

0.00

0.00 Rango del Día 0.00

0.00 Rango de 52 semanas 0.00

Precio Anterior

0.294

Precio de Apertura

-

Hora

Última hora de negociación

-

Volumen promedio (3 m)

-

Volumen financiero

-

Precio Promedio Ponderado

-

No news to show yet.

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

SIGHTP - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de GenSight Biologics?

El precio actual de las acciones de GenSight Biologics es 0.294 €

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de GenSight Biologics?

GenSight Biologics ha negociado en un rango de 0.00 € a 0.00 € durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
MDFEDuro Felguera SA	0.38275 € (30.19%)	32.64k
TRUEBSTruecaller AB	SEK 77.30 (13.34%)	58.19k
ATOPAtos SE	0.0034 € (13.33%)	169.03M
EXH5DBlackRock Asset Management Deutschland AG	44.21 € (9.76%)	1
GBSPWisdomTree Commodity Securities Limited	255.85 € (9.35%)	33
AGASOAvance Gas Holding Ltd	kr 34.80 (-43.87%)	59.06k
EAMOEAM Solar AS	kr 0.36 (-13.67%)	113.49k
PLTOpoLight ASA	kr 3.14 (-11.17%)	2.29k
CAPPCapgemini	165.95 € (-10.80%)	29.69k
EDENPEdenred SE	31.32 € (-7.61%)	31.46k
ATOPAtos SE	0.0034 € (13.33%)	169.03M
TITMTelecom Italia SpA	0.2797 € (2.08%)	4.65M
ISPMIntesa Sanpaolo Spa	4.501 € (0.58%)	859.57k
XBRANSXbrane Biopharma AB	SEK 0.1568 (-2.24%)	652.2k
BBVAEBanco Bilbao Vizcaya Argentaria SA	12.295 € (0.78%)	332.35k

TheFinalCD

TheFinalCD 8 minutos hace

https://x.com/Beppels1/status/1890449070923141202

The ELTP King

The ELTP King 9 minutos hace

Both are happening.

Nasdaq then buyout.

His intention is to suggest with certainty that we are headed for a reverse split and not a buyout.

TheFinalCD

TheFinalCD 9 minutos hace

GOOD CALL

GLYC BELL BUY INTO VOLUME AND BIG GAPPER

Cflores32097

Cflores32097 10 minutos hace

btw FP still owes all those investors he robbed

somberfox

somberfox 14 minutos hace

somberfox

somberfox 15 minutos hace

Cflores32097

Cflores32097 15 minutos hace

Oh yea 🦆🦆 is so 2022 we got a new scam

Cflores32097

Cflores32097 15 minutos hace

Hey Charles, what happened 🦆 🦆 go

Cflores32097

Cflores32097 16 minutos hace

LIONS GROUP CBD EVANS CYBER ZEN

Cflores32097

Cflores32097 19 minutos hace

Jzzi CBD HONEY GREG EVANS 55 UP

WolfofMia

WolfofMia 28 minutos hace

You don't have the energy, except for pompous reasons.

Got it.

longview1

longview1 29 minutos hace

My post keep getting removed, obviously making one of the Trump babies mad.

Dragonman1

Dragonman1 35 minutos hace

I hope we all benefit from this great beer co and see the awesome results in the report coming out soon, The bashers or the fool force is in for a big wake up call, northbound we go!

NickyCapone

NickyCapone 39 minutos hace

Warning‼️
All Shorties‼️

Last One Out is a Rotten Egg‼️

lakers17

lakers17 44 minutos hace

Yeah I feel the same way recently. Both the OTC and crypto are pissing me off. I keep buying more and more crypto on many of these dips. It's really boom or bust for me.

Guzzi62

Guzzi62 47 minutos hace

The main trial didn't fail dude, one primary endpoint failed, which is not the same.

That endpoint is in the process of being removed by the FDA which you likely knew already.

Why are you lying?

king_kong

king_kong 50 minutos hace

https://x.com/maxinvestor89/status/1891752794396229705?s=46&t=He3ILIizDMal7FFXIIgFjw

sharkey1

sharkey1 52 minutos hace

Correction, on the house bill 1396, copied from redit,

https://www.reddit.com/r/WallStreetbetsELITE/comments/1irl3m7/how_hr1396_could_impact_the_stock_market_generic/

can't find on google, it's in the ways and means committee
I think

capgain

capgain 53 minutos hace

Good morning, Larry, the cold is returning again.

walterc

walterc 54 minutos hace

mailconversation with IR
read the reply
- Appreciate your patience as we've worked to get you answers to some of these questions. Management is not in a position to provide an update on the commercial strategy with firm targets, timelines, etc. as that would constitute a material upda

valleybenedetto

valleybenedetto 54 minutos hace

There is ZERO dilution here. No warrants no overhead supply.

capgain

capgain 54 minutos hace

Happy Birthday, B2B!

DJPele

DJPele 56 minutos hace

Interesting update on the biosimilar candidate FYB206 with Merck's Keytruda:

"Regulatory developments in the U.S. indicate that the framework conditions for biosimilars continue to improve. The FDA has confirmed that extensive analytical data, together with the ongoing phase I trial,

SkeBallLarry

SkeBallLarry 56 minutos hace

*Super* " Happy BirthDay, back2basics " ..!!

GenSight Biologics

Delayed Upgrade Clock

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones